BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 9380417)

  • 1. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 3. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen and the endometrium.
    Barakat RR
    Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
    [No Abstract]   [Full Text] [Related]  

  • 7. One step forward or one step back with tamoxifen?
    Gelmon K
    Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
    Saim M; Cote JF; Morel O; Malartic C; Akerman G; Gray F; Barranger E
    Gynecol Obstet Fertil; 2008 Feb; 36(2):166-168. PubMed ID: 18249575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
    Jagavkar RS; Shakespeare TP; Stevens MJ
    Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
    [No Abstract]   [Full Text] [Related]  

  • 13. Mullerian adenosarcoma of the uterus associated with tamoxifen therapy.
    Arici DS; Aker H; Yildiz E; Tasyurt A
    Arch Gynecol Obstet; 2000 Sep; 264(2):105-7. PubMed ID: 11045336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Müllerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer.
    Carvalho FM; Carvalho JP; Motta EV; Souen J
    Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(1):17-20. PubMed ID: 10881074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.
    Bouchardy C; Verkooijen HM; Fioretta G; Sappino AP; Vlastos G
    J Clin Oncol; 2002 Nov; 20(21):4403. PubMed ID: 12409344
    [No Abstract]   [Full Text] [Related]  

  • 19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should tamoxifen users be screened for endometrial lesions?
    Neven P; Vergote I
    Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.